Biodesix Inc Ordinary Shares BDSX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.70
- Day Range
- $1.66–1.72
- 52-Week Range
- $1.15–2.21
- Bid/Ask
- $1.61 / $1.78
- Market Cap
- $248.25 Mil
- Volume/Avg
- 26,693 / 143,987
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 217
- Website
- https://www.biodesix.com
Comparables
Valuation
|
Metric
|
BDSX
|
VCYT
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 75.82 | 28.18 |
Price/Book Value | 6.85 | 2.29 | 4.59 |
Price/Sales | 2.78 | 6.32 | 7.16 |
Price/Cash Flow | — | 37.42 | 22.07 |
Price/Earnings
BDSX
VCYT
300685
Financial Strength
|
Metric
|
BDSX
|
VCYT
|
300685
|
|---|---|---|---|
Quick Ratio | 2.98 | 3.96 | 7.70 |
Current Ratio | 3.28 | 4.44 | 7.98 |
Interest Coverage | −3.85 | −13,015.40 | 272.48 |
Quick Ratio
BDSX
VCYT
300685
Profitability
|
Metric
|
BDSX
|
VCYT
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | −39.52% | 9.55% | 13.93% |
Return on Equity (Normalized) | −685.43% | 10.25% | 15.61% |
Return on Invested Capital (Normalized) | −45.23% | 9.19% | 13.94% |
Return on Assets
BDSX
VCYT
300685
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Plxwzjpbr | Tpqcl | $234.7 Bil | |||
| Danaher Corp
DHR
| Zskmmpmhfj | Czncpr | $198.9 Bil | |||
| IQVIA Holdings Inc
IQV
| Fhtvbzp | Qrggfyz | $42.8 Bil | |||
| Agilent Technologies Inc
A
| Vkvtpfwsgs | Vdhvh | $42.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Cvmtltcs | Fqx | $42.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Yjbdvsygt | Ntwjky | $31.4 Bil | |||
| Icon PLC
ICLR
| Fbsbzyz | Wymlr | $23.7 Bil | |||
| Waters Corp
WAT
| Qwcmhcxlv | Mdnv | $21.2 Bil | |||
| Illumina Inc
ILMN
| Wfdxcclp | Vrxspf | $20.7 Bil | |||
| Labcorp Holdings Inc
LH
| Tcmsbvld | Hsqqsrx | $18.6 Bil |
United States